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Jumping species—a mechanism for coronavirus
persistence and survival
Vineet D Menachery, Rachel L Graham and Ralph S BaricZoonotic transmission of novel viruses represents a significant
threat to global public health and is fueled by globalization, the
loss of natural habitats, and exposure to new hosts. For
coronaviruses (CoVs), broad diversity exists within bat
populations and uniquely positions them to seed future
emergence events. In this review, we explore the host and viral
dynamics that shape these CoV populations for survival,
amplification, and possible emergence in novel hosts.
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Introduction
In the past decade, molecular techniques have expanded
identification of zoonotic viruses, including coronaviruses
(CoVs) [1]. Traditionally, approaches for viral identification
have included culturing, antigen staining, electron micros-
copy, and serology [2]; however, these techniques were
inherently biased towards known viral families and were
largely insensitive to uncharacterized species. In contrast,
molecular diagnostics rapidly identified unknown patho-
gensstartingwithSin Nombre virus in thelate20thcentury,
continuing with SARS-CoV in the early part of this century,
and most recently with MERS-CoV [3–5]. As the molecular
approaches improved, these techniques have become stan-
dard in identifying infectious agents in both acute and
chronic disease settings. Coupled with reduced cost, these
new approaches have permitted application for pathogen
discovery; the number of known CoVs has increased sub-
stantially, aided by both surveys of animal populations and
infrastructure investments to improve diagnostic capacity
in disease hotspots [6]. Importantly, the resulting inventory
illustrates the broad diversity harbored in zoonotic hosts
and the presence of quasi-species that may serve as areservoir for CoV persistence. In this review, we examine
how both bat hosts and the CoVs that they harbor may be
uniquely positioned to seed future emergence events,
especially as human populations increase and penetrate
the undeveloped regions of the world.
Bats reservoirs: shaping virus emergence
While numerous animals have been surveyed in the past
decade, bats continue to be among the most abundant
source for novel viral sequences [7]. Bat species are
among the oldest mammals and represent 20% of mam-
malian diversity [8]; they exist and occupy diverse niches
from isolated individuals to large commensal colonies
with broad geographic ranges that can span thousands
of miles. Importantly, their great diversity and long co-
evolutionary relationships with pathogens provide the
opportunity for cross species mixing and maintenance
of quasi-species pools of viruses that can infect a range of
hosts [9,10]. Yet, despite harboring such a diverse assort-
ment of viruses, surveyed bats rarely exhibit signs of
disease. Several hypotheses have been proposed to
explain these asymptomatic infections. One postulates
that bats, the only flying mammal, produce large amounts
of reactive oxygen species (ROS) and, in response, have
modulated genes to limit oxidative stress [11], which may
result in reduced viral replication and pathogenesis [12].
Similarly, a modified innate immune response may also
contribute to the diverse viral pools harbored by bats.
Known PYHIN (PYRIN and HIN domain-containing)
genes within the inflammasome pathway and natural
killer immunoglobulin-like receptors (KIRs) are absent
or significantly reduced in some surveyed bat species,
potentially limiting disease and damage following infec-
tion [11,13]. In addition, constitutive expression of bat
interferon subtypes likely limits disease but permits low-
level viral infection to remain intact [14]. A third possi-
bility suggests a commensal relationship between the
harbored viruses and bat species [15]. As primarily iden-
tified from enteric samples (i.e., bat guano), these pools of
viruses may serve a critical role in the bat microbiome to
prime immunity, a concept similarly proposed for humans
with herpes viruses [16]. Finally, enteric infection repre-
sents a significantly different tissue than the respiratory
tract in terms of disease and adaptive immunity; thus,
virus tropism differences between species and tissues
may also contribute to limiting disease in bats. Similarly,
while recent work has shown intact elements of adaptive
immunity in bat species [17–19], the enteric location may
generate a dampened adaptive response that permits viral
maintenance similar to the members of the microbiome in
humans [20]. Together, these factors likely work in 
combination and indicate how diverse pools of CoV 
quasi-species can survive in bat populations.
While bat species maintain factors that permit virus 
persistence, the unique host environment also promotes 
broad diversity in CoV quasi-species pools. As a result of 
flight, accumulation of ROS species may occur for short 
periods of time and have been shown to have mutagenic 
effects, potentially overwhelming CoV proofreading 
repair and/or altering viral polymerase fidelity and 
increasing species diversity, a possible key to cross-spe-
cies transmission [21]. Similarly, the constitutive expres-
sion of type I IFN in bat hosts may select for advanta-
geous viral mutations that enhance resistance to innate 
immune antiviral defense pathways and provide a repli-
cation advantage, especially after cross species transmis-
sion [14]. Conversely, the absence of key inflammatory 
mediators in bat species provides no selective pressure to 
minimize these responses [13]; subsequently, infection of 
a new host could result in massive and pathogenic inflam-
mation responses, as seen with both SARS-CoV and 
MERS-CoV infections in humans [22,23]. Overall, the 
unique aspects that permit quasi-species pools of viruses 
in bats also contribute to their diversity and potential to 
emerge in new species.
Balancing act: honing CoV survival and 
emergence
While bats provide a critical  foreground,  emergence  of 













Balancing coronavirus emergence. Bat populations maintain a unique enviro
viruses. To overcome species barriers, CoV must modify some key viral fac
fidelity and gene modulation. Using these processes, CoVs shape their prot
while modifying others (non-structural proteins, accessory proteins, spike S
tools necessary for emergence.overcome species barriers without sacrificing the form
or function of other important elements. This dichot-
omy in CoVs is governed by two distinct mechanisms:
fidelity and gene acquisition (Figure 1). A major limita-
tion to RNA virus capacity is the need to minimize
sequence length to survive error catastrophe [24]. How-
ever, CoVs, as some of the largest members of the
Nidovirales order, have overcome this barrier by pro-
ducing a large replication complex with known RNA
synthesis and modification activities that include a
proofreading machine, mediated primarily via the 30–
50 exoribonuclease activity of non-structural protein
(nsp) 14 [25]. As such, this large and complex RNA
replication machinery has allowed CoVs to achieve
upwards of 32 kb in size while maintaining the func-
tional components required for viability. Coupled with
robust fidelity, CoVs have also used recombination,
horizontal gene transfer, gene duplication, and alterna-
tive open reading frames to expand the functional
capacity for its current and new hosts [26]. Together,
both fidelity and gene acquisition have honed and
refined CoV proteins, which can be divided into three
broad groups based on selective pressure: spike, con-
served, and variable proteins (Figure 1). For a novel
CoV to emerge, these three groups must function in
harmony, providing sufficient changes to overcome spe-
cies barriers while maintaining key viral functions.
Keying in: spike drives emergence
Charged with binding the host receptor, the spike protein
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nment that facilitates survival and maintenance of diverse pools of
tors while maintaining others. Two mechanisms govern this balance:
eins conserving some (viral enzymes, structural proteins, spike S2)
1). The resulting pools therefore maintain viability while also possessing
for host immunity [27]. Divided into two parts, the S1
portion forms the globular head of the spike trimer
(Figure 2a), drives receptor engagement, and is variable
across and within CoV groups (Figure 2b) [28,29]. In
contrast, the S2 domain maintains the entry machinery
and requires more conservation across the CoV family
(Figure 2a,b). With binding required for infection, muta-
tions within S1, and most notably, the receptor-binding
domain (RBD), have been thought to be critical for CoV
emergence [30]. Using chimeric viruses employing civet,
early, and middle-phase spike proteins demonstrated
viability for the closely related strains in human cells
[31,32]. However, for some strains, such as SZ16 and bat-
derived HKU3-CoV, the closest known SARS-CoV pro-
genitors at the time, progeny virions were not recoverable
in Vero or primary human airway epithelial cells, despite
evidence of RNA replication [30,32]. To overcome this
barrier, single humanizing mutation K479N was intro-
duced into SZ16 and a chimeric HKU3 virus containing
the RBD of SARS-CoV was designed and permitted
replication, likely due to its capacity to bind the human
ACE2 receptor [30,31]. A similar approach was used with
group 2C CoV HKU5; substitution of the entire ecto-
domain from SARS-CoV spike resulted in an HKU5 virus
that was able to infect human cells [33]. Together, the
data argue that the ability of the spike to bind receptor is












Conservation and modification of spike protein. The CoV spike protein is cr
required for infection of new species, the spike protein must also maintain i
from Ref. [53]), dividing the protein into S1 globular head portions (blue), an
set of representative coronaviruses from all four genogroups using alignmen
(v.9.1.5) and visualized in EvolView (evolgenius.info). Trees show the degreeHowever, more recent advances identified bat CoV spike
proteins that could produce robust infection without
manipulation [34,35]. Building from sequences closely
related to the epidemic SARS-CoV strains [36], chimeric
viruses employing the spike sequences from SHC014 and
WIV1 clusters produced CoVs capable of replicating in
human cells and causing disease in vivo [34,35]. Coupled
with the discovery of sequences even more closely related
to the epidemic SARS-CoV strains and evidence of robust
S1 recombination [37], the results suggest that extensive
mutation of the spike RBD may not be the only correlate
for infection of human hosts. Notably, both chimeric
viruses were attenuated relative to the epidemic strain,
suggesting that adaptation within the new host contrib-
utes to disease and pathogenesis [34,35]. Yet, it remains
unclear if these mutations occur exclusively within the S1
portion of spike or if subtle changes in the S2 region
contribute to enhanced disease by interfacing with sur-
face and intracellular proteases that function in entry and
egress [38,39].
Mainstays and accessories: adding tools but
keeping a base
The CoV spike protein captures a critical dichotomy
necessary for emergence, employing enough novelty in
its S1 region to bind new host receptors while conserving
























































































Current Opinion in Virology
itical receptor binding and entry. Therefore, while modification is likely
ts entry mechanism. (a) Structure of MHV-CoV spike trimer (adapted
d S2 conserved stalk (green). (b) Heat maps were constructed from a
t data paired with neighbor-joining phylogenetic trees built in Geneious
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Maintenance and change the CoV backbone. Changes to the CoV backbone can aid emergence, but must be balanced against conservation of
other elements. (a) Genomic structure of SARS-CoV with proteins predicted to be conserved (blue), variable (red), or in between (purple). (b) Heat
maps were constructed from a set of representative coronaviruses from all four genogroups using alignment data paired with neighbor-joining
phylogenetic trees built in Geneious (v.9.1.5) and visualized in EvolView (evolgenius.info). Trees show the degree of genetic similarity of ORF6,
NSP2, nucleocapsid, and NSP14 across genera.critical for infection of new hosts, changing the spike
protein alone is not sufficient to cause epidemic disease
[34,35]; therefore, changes within the backbone are also
necessary to speed emergence. Yet, the same dichotomy
seen with the spike glycoproteins is necessary in balanc-
ing change within the CoV backbone. Certain elements,
most notably accessory proteins, may be added or modi-
fied to enhance infection within new hosts. In contrast,other viral motifs and proteins must be conserved to
maintain virus functionality. For each, CoV fidelity,
recombination, and evolutionary pressure hone and refine
these genes, providing a framework for emergence in a
new species to occur.
For highly conserved viral functions, the presence of CoV
fidelity machinery provides an important means to
maintain these activities in the context of an expansive
genome. Broadly, these conserved viral proteins can be
categorized into structural and enzymatically active
groups (Figure 3a). For structural proteins, including
the nucleocapsid (N), matrix (M), and envelope (E), high
within-group conservation is maintained, with more mod-
est similarity seen across the entire CoV family
(Figure 3b). This level of conservation, similar to the
S2 portion of spike, suggests the need to maintain func-
tional interaction for the formation of viral particles.
Similarly, ORF1ab polyprotein genes find a distinction,
with genes involved in protease cleavage and the replica-
tion complex having high levels of similarity across CoV
families. For example, enzymatically active proteins, such
as nsp14 and nsp16, maintain very high conservation,
likely due to their specific functions in proofreading
and 20O methylation of nascent RNA [25,40] (Figure 3).
For both groups, some mutational space is available,
accounting for differences across the family; however,
function must be maintained to ensure CoV survival.
In contrast, accessory proteins distinguish CoV infections
from each other, with high variability across the family,
allowing viruses to adapt to current and novel hosts. The
majority of these genes have been characterized in the
context of antagonizing host immune responses, most
notably type I IFN pathways [41]. However, the func-
tions of these proteins may extend beyond host immunity
and may be species-specific. For example, the SARS-CoV
accessory protein ORF6 was initially characterized based
on its capacity to interfere with STAT1 nuclear localiza-
tion [42]. Further study indicated that modulation of the
IFN responses was a byproduct of karyopherin transport
and had a significant impact on host modulation beyond
type I IFN at late times post-infection [42,43]. Notably,
protein-coding sequences similar to SARS-CoV ORF6 are
not readily detected beyond the group 2B CoV family,
suggesting a more recent acquisition (Figure 3). Similarly,
SARS ORF8 has undergone significant modification, with
a 29-nucleotide deletion found in epidemic strains result-
ing in two novel proteins (ORF8a and 8b) [44]; coupled
with reports of human isolates with larger deletions, these
results suggest that the epidemic strain may be removing
a protein only necessary for survival in bats [45]. Even for
viral genes within the ORF1ab polyprotein, significant
changes can be noted across viral families. Nsp2, cleaved
co-translationally from nsp3 and present in some form in
all CoV, is responsible for a wide variety of activities and
has minimal cross-genus sequence homology, although
within groups, similarities are variable (Figure 3) [46–48].
Together, these results argue that across the CoV family,
significant differences in accessory proteins can modulate
and change infection aspects, including kinetics, severity,
and species.
Yet, even within more closely related subgroups, novel
genes can appear from diverse sources and potentiallyfuel emergence. The recent discovery and characteriza-
tion of two closely related SARS-like viruses, WIV1 and
WIV16, revealed a novel acc.essory protein, ORFX,
which was not found in the epidemic SARS-CoV strains
[49]. Containing no sequence homology to any known
proteins, the novel gene modulates type I IFN and
activates NFkB signaling pathways, suggesting a role
in modulating host immunity. While the majority of
accessory proteins are thought to be acquired from the
host, recent work suggests that novel CoV proteins can
even be taken from other pathogens [50]. Identification of
a novel coronavirus (Ro-BatCoV GCCDC1) also revealed
the presence of a unique 30 protein with homology to a
known reovirus gene; a similar finding with the hemaglu-
tinin-esterase in a subset of CoV further suggests the
possibility of recombination events occurring between
viral families [8,51]. Together, the results indicate that
CoVs can sample, acquire, and maintain a range of diverse
proteins that may be critical for maintenance in natural
hosts and emergence in new species.
Conclusion
With permissive natural hosts and inherent tools to bal-
ance gene modulation/maintenance, CoVs are uniquely
positioned to emerge in novel hosts. For both the epi-
demic strains (SARS and MERS-CoV) and contemporary
human strains (HCov 229E, NL63, OC43), significant
human disease may be the outcome of cross-species
transmission. Importantly, opportunities exist to utilize
metagenomics data to prepare and possibly mitigate
future emergence events. In seeking these goals,
researchers need to consider the factors that drive emer-
gence. In determinations of potential threats, exploring
the variable spike S1 portion of bat CoVs to identify
viruses capable of binding to human receptors is key.
Similarly, targeting highly conserved genes like the S2
region of spike has allowed for the development of
therapeutics with broad efficacy against current and
potential future CoVs that emerge [28,52]. In addition,
understanding the mechanisms and impact of highly
variable genes provides another metric for threat and
identifies targets for the generation of attenuated vaccine
strains. Together, these approaches provide a platform to
leverage our understanding of how CoVs emerge from bat
sources to prepare and potentially stem future disease
outbreaks. With globalization, habitat loss in developing
nations, and uneven public health infrastructures, the
survival and amplification of novel CoVs in bat popula-
tions is now a lurking threat that requires immediate
attention and preparation.
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